Skip to main content
. 2020 Jun 26;11:660. doi: 10.3389/fgene.2020.00660

TABLE 2.

The summary of identified integration sites by all three datasets (Nanopore/Illumina/Liu et al.) after reads number filtration.

Breakpoint* Reads number (N/I/Liu) HPV16 gene Chromosome Func_refGene Gene_refGene GeneDetail_refGene (bp) Map Sanger Verified
HPV16:2804,chr20:32516985 406/1439/940 E1/E2 Chr20 Intergenic CHMP4B, RALY-AS1 74812; 63309 20q11.22
HPV16:3327,chr6:7328094 51/0/131 E2 Chr6 Intronic CAGE1 . 6p24.3
HPV16:2623,chr6:8814271 37/64/46 E1 Chr6 Intergenic LOC100506207, TFAP2A 28593; 1582645 6p24.3
HPV16:5534,chrX:20464412 132/168/43 L2 ChrX Intergenic RPS6KA3, CNKSR2 179662; 928004 Xp22.12
HPV16:4680,chr6:7326060 43/6/22 L2 Chr6 Downstream CAGE1 . 6p24.3
HPV16:3163,chrX:20462930 50/0/21 E2 ChrX Intergenic RPS6KA3, CNKSR2 178180; 929486 Xp22.12
HPV16:7619,chr2:99404946 5/1/0 LCR Chr2 Intergenic LOC101927070, KIAA1211L 16585; 5363 2q11.2 S
HPV16:3873,chr2:197526852 5/4/0 E5 Chr2 Intronic CCDC150 . 2q33.1
HPV16:2891,chr6:12645768 13/25/12 E2 Chr6 Intergenic EDN1, PHACTR1 348341; 71120 6p24.1
HPV16:3182,chr20:32516399 23/0/8 E2 Chr20 Intergenic CHMP4B, RALY-AS1 74226; 63895 20q11.22
HPV16:850,chr20:32515476 13/2/8 E7 Chr20 Intergenic CHMP4B, RALY-AS1 73303; 64818 20q11.22
HPV16:4453,chr20:32472390 25/19/4 L2 Chr20 Intergenic CHMP4B, RALY-AS1 30217; 107904 20q11.22
HPV16:5744,chr11:103893587 37/62/2 L1 Chr11 Intronic PDGFD . 11q22.3
HPV16:7519,chr2:197519914 19/56/0 LCR Chr2 Intronic CCDC150 . 2q33.1 S
HPV16:4489,chr11:31749949 17/32/0 L2 Chr11 Intronic ELP4 . 11p13 S
HPV16:2110,chr2:99396966 17/25/0 E1 Chr2 Intergenic LOC101927070, KIAA1211L 8605; 13343 2q11.2 S
HPV16:322,chr20:32486709 7/21/0 E6 Chr20 Intergenic CHMP4B, RALY-AS1 44536; 93585 20q11.22 S
HPV16:1276,chr18:50054 5/20/14 E1 Chr18 Intergenic LOC102723376, ROCK1P1 34124; 59011 18p11.32
HPV16:4394,chr12:17224129 3/15/2 L2 Chr12 Intergenic SKP1P2, LINC02378 80567; 510628 12p12.3
HPV16:4834,chrX:20461879 41/12/0 L2 ChrX Intergenic RPS6KA3, CNKSR2 177129; 930537 Xp22.12 S
HPV16:1037,chrX:20445300 2/11/0 E1 ChrX Intergenic RPS6KA3, CNKSR2 160550; 947116 Xp22.12
HPV16:6618,chr20:32506419 3/9/12 L1 Chr20 Intergenic CHMP4B, RALY-AS1 64246; 73875 20q11.22
HPV16:2638,chr20:32502300 4/8/0 E1 Chr20 Intergenic CHMP4B, RALY-AS1 60127; 77994 20q11.22
HPV16:1155,chrX:20447276 27/8/0 E1 ChrX Intergenic RPS6KA3, CNKSR2 162526; 945140 Xp22.12 S
HPV16:214,chr6:7242229 6/7/0 E6 Chr6 Intronic RREB1 . 6p24.3
HPV16:4307,chr13:74240744 2/6/0 L2 Chr13 Intergenic LINC00392, KLF12 78728; 19405 13q22.1
HPV16:883,chr20:32487936 4/5/5 E1 Chr20 Intergenic CHMP4B, RALY-AS1 45763; 92358 20q11.22
HPV16:4250,chr2:197550764 2/4/0 L2 Chr2 Intronic CCDC150 . 2q33.1
HPV16:7362chr18:12717 8/3/0 LCR Chr18 ncRNA_intronic LOC102723376 . 18p11.32
HPV16:4405,chr2:99438640 1/3/2 L2 Chr2 Exonic KIAA1211L . 2q11.2
HPV16:462,chr20:30942164 8/2/0 E6 Chr20 Intergenic KIF3B, ASXL1 19353; 3983 20q11.21 S
HPV16:6558,chr2:99431140 3/1/0 L1 Chr2 Intronic KIAA1211L . 2q11.2
HPV16:7139,chr20:32478733 169/0/0 L1 Chr20 Intergenic CHMP4B, RALY-AS1 36560; 101561 20q11.22 S
HPV16:4276,chr20:32502143 51/0/0 L2 Chr20 Intergenic CHMP4B, RALY-AS1 59970; 78151 20q11.22 S
HPV16:4029,chr11:103891933 21/0/0 E5 Chr11 Intronic PDGFD . 11q22.3 S
HPV16:3312,chr6:17081322 8/0/0 E2 Chr6 Intergenic LOC101928433, STMND1 314208; 21167 6p22.3 S
HPV16:3295,chr11:31761709 6/0/0 E2 Chr11 Intronic ELP4 . 11p13 S
HPV16:5311,chr1:455824 6/0/0 L2 Chr1 Intergenic OR4F16, LOC101928626 87227; 106936 1p36.33
HPV16:4027,chr11:103891932 4/0/0 E5 Chr11 Intronic PDGFD . 11q22.3
HPV16:6681,chr10:80475 4/0/0 L1 Chr10 Intergenic NONE, TUBB8 NONE; 12353 10p15.3
HPV16:1570,chrX:20385416 4/0/0 E1 ChrX Intergenic RPS6KA3, CNKSR2 100666; 1007000 Xp22.12
HPV16:4508,chr1:143415731 3/0/0 L2 Chr1 Intergenic LOC102723769, MIR6077 213492; 257190 1q21.1
HPV16:6840,chr6:171021105 3/0/0 L1 Chr6 Intergenic PDCD2, NONE 127325; NONE 6q27
HPV16:6840,chr1:547221 3/0/0 L1 Chr1 Intergenic OR4F16, LOC101928626 178624; 15539 1p36.33
HPV16:6840,chr1:547739 3/0/0 L1 Chr1 Intergenic OR4F16, LOC101928626 179142; 15021 1p36.33
HPV16:6305,chr2:197525082 3/3/0 L1 Chr2 Intronic CCDC150 . 2q33.1
HPV16:4730,chr1:10270 3/0/0 L2 Chr1 Intergenic NONE, DDX11L1 NONE; 1604 1p36.33
HPV16:6929,chr2:99443220 2/0/0 L1 Chr2 Intronic KIAA1211L . 2q11.2
HPV16:1469,chr3:189605104 2/0/0 E1 Chr3 Intronic TP63 . 3q28
HPV16:4730,chrX:155259784 2/0/0 L2 ChrX Intergenic DDX11L16, NONE 1936; NONE Xq28
HPV16:4732,chr2:114360505 2/0/0 L2 Chr2 ncRNA_intronic DDX11L2 . 2q13
HPV16:2621,chr20:3560423 2/0/0 E1 Chr20 Intronic ATRN . 20p13
HPV16:4732,chr18:10186 2/0/0 L2 Chr18 Intergenic NONE, LOC102723376 NONE; 1889 18p11.32
HPV16:3324,chr6:7328088 2/0/0 E2 Chr6 Intronic CAGE1 . 6p24.3
HPV16:6840,chr1:547835 2/0/0 L1 Chr1 Intergenic OR4F16, LOC101928626 179238; 14925 1p36.33
HPV16:4793,chr12:80918599 2/0/0 L2 Chr12 Intronic PTPRQ . 12q21.31
HPV16:3340,chr15:40890192 2/0/0 E2/E4 Chr15 Intronic KNL1 . 15q15.1
HPV16:4732,chr1:10164 2/0/0 L2 Chr1 Intergenic NONE, DDX11L1 NONE; 1710 1p36.33
HPV16:6899,chr2:72209094 2/0/0 L1 Chr2 Intergenic DYSF, CYP26B1 295201; 147273 2p13.2
HPV16:3340,chr20:35719229 0/35/0 E2/E4 Chr20 Intronic RBL1 . 20q11.23
HPV16:3340,chr12:81091809 0/96/0 E2/E4 Chr12 Intergenic PTPRQ, MYF6 17841; 9599 12q21.31
HPV16:1355,chr2:99429402 0/6/0 E1 Chr2 Intronic KIAA1211L . 2q11.2
HPV16:4782,chr2:99435835 0/6/0 L2 Chr2 Intronic KIAA1211L . 2q11.2
HPV16:1030,chr9:123681030 0/4/0 E1 Chr9 Intronic TRAF1 . 9q33.2
HPV16:3378,chr17:69506855 0/4/0 E2/E4 Chr17 Intergenic CASC17, LINC02095 308535; 511137 17q24.3
HPV16:1515,chr21:39554078 0/3/0 E1 Chr21 Intergenic DSCR8, DSCR10 25473; 24172 21q22.13
HPV16:1916,chr16:79637361 0/3/0 E1 Chr16 Intergenic MAF, MAFTRR 2739; 117848 16q23.2
HPV16:2117,chr1:240419064 0/3/0 E1 Chr1 Intronic FMN2 . 1q43
HPV16:3050,chr17:65126150 0/3/0 E2 Chr17 Intronic HELZ . 17q24.2
HPV16:3337,chr14:46921971 0/3/0 E2/E4 Chr14 ncRNA_intronic LINC00871 . 14q21.2
HPV16:4399,chr2:127164444 0/3/0 L2 Chr2 Intergenic LINC01941, GYPC 288882; 249067 2q14.3
HPV16:4409,chr3:45985168 0/3/0 L2 Chr3 Intronic CXCR6, FYCO1 . 3p21.31
HPV:16:5685,chr3:56156825 0/3/0 L1 Chr3 Intronic ERC2 . 3p14.3
HPV16:7086,chr2:99457820 0/3/0 L1 Chr2 Intronic KIAA1211L . 2q11.2
HPV16:2724,chr20:30948621 0/0/8 E1 Chr20 Intronic ASXL1 20q11.21
HPV16:3883,chr3:156990726 0/0/4 E5 Chr3 Intronic VEPH1 3q25.31
HPV16:3344,chr6:7327990 0/89/43 E2 Chr6 Intronic CAGE1 . 6p24.3
HPV16:1381,chr11:31187618 0/3/0 E1 Chr11 Intronic DCDC1 . 11p13
HPV16:1891,chr20:60384079 0/3/0 E1 Chr20 Intronic CDH4 . 20q13.33
HPV16:2075,chr12:39215471 0/3/0 E1 Chr12 Intronic CPNE8 . 12q12
HPV16:2237,chr4:28262779 0/3/0 E1 Chr4 Intergenic LINC02261,MIR4275 978932;558425 4p15.1
HPV16:2716,chr13:74250432 1/3/0 E1 Chr13 Intergenic LINC00392,KLF12 88416;9717 13q22.1
HPV16:3340,chr12:81091909 0/58/0 E2/E4 Chr12 Intergenic PTPRQ,MYF6 17941;9499 12q21.31
HPV16:2724,chr20:30948899 0/11/0 E1 Chr20 Intronic ASXL1 . 20q11.21
HPV16:3340,chr1:212166417 0/27/0 E2/E4 Chr1 Intronic INTS7 . 1q32.3

*Breakpoint: each breakpoint was named by combined breakpoint site of HPV genome, chromosome and chromosome location of human breakpoint; Reads Number: N (Nanopore), I (Illumina), Liu (Liu et al.), Nanopore reads number cut-off value is 2, and Illumina reads number cut-off value is 3. There is no cut-off value for integration sites which overlapped by different sequencing platforms. Lane of GeneDetail_refGene listed the distance of integration sites with the nearby genes. S:Sanger Verified.